Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study

Endocrine-Related Cancer

Volumn 14, Issue 2, 2007, Pages 473-482

  Zatelli, Maria Chiara ^a   Torta, Mirella ^b   Leon, Antonette ^c   Ambrosio, Maria Rosaria ^a   Gion, Massimo ^c   Tomassetti, Paola ^d   De Braud, Filippo ^e   Delle Fave, Gianfranco ^f   Dogliotti, Luigi ^b   Degli Uberti, Ettore C ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Regional General Hospital   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CHROMOGRANIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; IMMUNORADIOMETRIC ASSAY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; RECEIVER OPERATING CHARACTERISTIC;

ADULT; CHROMOGRANIN A; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; ITALY; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547821431     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0001     Document Type: Article

References (29)

1. Baudin E, Bidart JM, Bachelot A, Ducreux M, Elias D, Ruffié P & Schlumberger M 2001 Impact of chromogranin A measurement in the work-up of neuroendocrine tumors. Annals of Oncology 12 S79-S82.
2. Bernini GP, Moretti A, Ferdeghini M, Ricci S, Letizia C, D'Erasmo E, Argenio GF, Argenio GF & Salvetti A 2001 A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumors. British Journal of Cancer 84 636-642.
3. Canale MP & Bravo EL 1994 Diagnosis specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction. Journal of Clinical Endocrinology and Metabolism 78 1139-1144.
4. Chu QD, Hill HC, Douglass HO Jr, Driscoll D, Smith JL, Nava HR & Gibbs JF 2002 Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Annals of Surgical Oncology 9 855-862.
5. Degorce F, Goumon Y, Jacquemart L, Vidaud C, Bellanger L, Pons-Anicet D, Seguin P, Metz-Boutigue MH & Aunis D 1999 A new human chromogranin A (CGA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain. British Journal of Cancer 79 65-71.
6. Eriksson B, Arnberg H, Lindgren PG, Lorelius LE, Magnusson A, Lundqvist G, Skogseid B, Wide L, Wilander E & Oberg K 1990 Neuroendocrine pancreatic tumours: clinical presentations, biochemical and histopathological findings in 84 patients. Journal of Internal Medicine 228 103-113.
7. Ferrari L, Seregni E, Lucignani G, Bajetta E, Martinetti A, Aliberti G, Pallotti F, Procopio G, Della Torre S, Luksch R et al. 2004 Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors. International Journal of Biological Markers 19 295-304.
8. Guignat L, Bidart JM, Nocera M, Comoy E, Schlumberger M & Baudin E 2001 Chromogranin A and the α-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma. British Journal of Cancer 84 808-812.
9. Gullo L, Migliori M, Falconi M, Pederzoli P, Bettini R, Casadei R, Delle Fave G, Corleto VD, Ceccarelli C, Santini D et al. 2003 Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. American Journal of Gastroenterology 98 2435-2439.
10. Lamberts SW, Hofland LJ & Nobels FR 2001 Neuroendocrine tumor markers. Frontiers in Neuroendocrinology 22 309-339.
11. Leon A, Torta M, Dittadi R, degli Uberti E, Ambrosio MR, Delle Fave G, De Braud F, Tomassetti P, Gion M & Dogliotti L 2005 Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational study. International Journal of Biological Markers 20 156-168.
12. Madeira I, Terris B, Voss M, Denys A, Sauvanet A, Flejou JF, Vilgrain V, Belghiti J, Bernades P & Ruszniewski P 1998 Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 43 422427.
13. Modlin IM, Lye KD & Kidd M 2003 A 5-decade analysis of 13 715 carcinoid tumors. Cancer 97 934-939.
14. Nehar D, Lombard-Bohas C, Olivieri S, Claustrat B, Chayvialle JA, Penes MC, Sassolas G & Borson-Chazot F 2004 Interest of chromogranin A for diagnosis and follow-up of endocrine tumours. Clinical Endocrinology 60 644-652.
15. Nobels FRE, Kwekkeboom DJ, Coopmans W, Schoenmakers CHH, Lindemans J, De Herder WW, Krenning EP, Bouillon R & Lamberts SWJ 1997 Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the α-subunit secreting of glycoprotein hormones. Journal of Clinical Endocrinology and Metabolism 82 2622-2628.
16. Nobels FRE, Kwekkeboom DJ, Boiullon R & Lamberts SW 1998 Chromogranin A: its clinical value as markers of neuroendocrine tumours. European Journal of Clinical Investigation 28 431-440.
17. Orr DF, Chen T, Johnsen AH, Chalk R, Buchanan KD, Sloan JM, Rao P & Shaw C 2002 The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomic strategy. Proteomics 2 1586-1600.
18. Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S et al. 2005 Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocrine Related Cancer 12 1083-1092.
19. Peracchi M, Conte D, Gebbia C, Penati C, Pizzinelli S, Arosio M, Corbetta S & Spada A 2003 Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. European Journal of Endocrinology 148 39-43.
20. Rindi G & Kloppel G 2004 Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 80 12-15.
21. Schurmann G, Raeth U, Wiedenmann B, Buhr H & Herfarth C 1992 Serum chromogranin A in the diagnosis and the follow-up of neuroendocrine tumors of the gastroenteropancreatic tract. World Journal of Surgery 16 697-702.
22. Seregni E, Ferrari L, Bajetta E, Martinetti A & Bombardieri E 2001 Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Annals of Oncology 12 S69-S72.
23. Stivanello M, Berruti A, Torta M, Termine A, Tampellini M, Gorzegno G, Angeli A & Dogliotti L 2001 Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience. Annals of Oncology 12 S73-S77.
24. Stridsberg M, Oberg K, Li Q, Engström U & Lundqvist G 1995 Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C, (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. Journal of Endocrinology 144 49-59.
25. Stridsberg M, Eriksson B, Öberg K & Janson ET 2003 A comparison between three commercial kits for chromogranin A measurements. Journal of Endocrinology 177 337-341.
26. Syversen U, Ramsrad H, Gamme K, Qvigstad G, Falkmer S & Waldum HL 2004 Clinical significance of elevated serum chromogranin A levels. Scandinavian Journal of Gastroenterology 39 969-973.
27. Taupenot L, Harper KL & O'Connor DT 2003 The chromogranin- secretogranin family. New England Journal of Medicine 348 1134-1149.
28. Tomassetti P, Migliori M, Simoni P, Casadei R, De Iasio R, Corinaldesi R & Gullo L 2001 Diagnostic value of plasma chromogranin A in neuroendocrine tumours. European Journal of Gastroenterology and Hepatology 13 55-58.
29. Tomassetti P, Campana D, Piscitelli L, Casadei R, Santini D, Nori F, Morselli-Labate AM, Pezzulli R & Corinaldesi R 2005 Endocrine pancreatic tumors: factors correlated with survival. Annals of Oncology 16 1806-1810.